Industry News
Prana candidate reduces Abeta levels
Prana research shows PBT2 reduces Abeta and improves cognition in mouse model [ + ]
Mesoblast targets AMD and retinopathy
Mesoblast's allogeneic stem cells in trial for diabetic retinopathy and age-related macular degeneration. [ + ]
SCS wins media patent
Stem Cell Sciences wins UK patent covering enzyme inhibitor cocktail [ + ]
Medigard selects site for trials
Gold Coast's Medigard chooses Genomics Research Centre at Griffith Uni for trials [ + ]
Director of API retires
Barry Frost will be leaving the company after serving on the board for 15 years [ + ]
Cytopia adds and subtracts
Cytopia appoints new scientific advisor, closes US east coast office [ + ]
Gro for Tissue Therapies
Tissue Therapies to commence human VitroGro trials locally [ + ]
First steps for Bionomics' anti-anxiety drug
Bionomics completes GMP synthesis of anxiety drug candidate [ + ]
Extra indication for VivaGel
Starpharma to adapt VivaGel as bacterial vaginosis treatment [ + ]
Brain Resource licenses behavioural health technology
Reaches a three-year exclusive arrangement with OptumHealth [ + ]
Positive results for Select
Select Vaccines' bird flu candidate promising in pre-clinical trial [ + ]
Phosphagenics appoints pharma veteran
Michael Ashton joins Phosphagenics' board [ + ]
Prana co-founder addresses US Senate
Rudolph Tanzi provides testimony on Alzheimer's in front of the Special Committee on Ageing [ + ]
The Wood on Clinuvel
Clinuvel goes OS for expertise [ + ]
Somnomed finds UK distribution partner
Somnomed to distribute its snoring therapy to UK market through Intus Healthcare [ + ]
